Table 2.

Available antidiabetic agents for treatment of type 2 diabetes

Sulfonylureas

First generation

Second generation

Third generation

Modified release

Glinides

Nonsulfonylureic

Amino acid derivatives

Biguanides

Metformin

Thiazolidinediones

Rosiglitazone

Pioglitazone

Fixed-dose oral hypoglycemic agents combinations

α-Glucosidase inhibitors

Acarbose

Voglibose

Insulin

Regular

Long-acting

Pre-mixed

Insulin analogs

Rapid-acting

Long-acting

Inhaled

GLP-1 analogs

Dipeptidyl peptidase-4 inhibitors

Amylin analog